跳至主要内容
临床试验/RBR-4ttd9yc
RBR-4ttd9yc尚未招募不适用

se of anti-inflammatory eye drops after selective laser trabeculoplasty: a randomized clinical trial

Hospital Oftalmológico de Brasília0 个研究点开始时间: 2022年4月4日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18Y 至 0(—)

入选标准

  • Patients with primary open-angle glaucoma or ocular hypertension or pseudoexfoliative glaucoma or pigmentary glaucoma or pigment dispersion syndrome, with inadequate control of intraocular pressure or intolerance to topical treatment, that will undergo selective laser trabeculoplasty (SLT). Patients approached must be at least 18 years of age on the date of the procedure and be able to undergo post-SLT follow-up for at least 12 months

排除标准

  • Angle-closure glaucoma; Any previous glaucoma surgery; Any previous corneal procedure (refractive surgery, intrastromal rings, corneal transplant); Pregnant women

研究者

发起方
Hospital Oftalmológico de Brasília

相似试验

se of anti-inflammatory eye drops after laser... | 临床试验